Jpmorgan Chase & CO Eli Lilly & CO Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 18,174,386 shares of LLY stock, worth $14.5 Billion. This represents 1.32% of its overall portfolio holdings.

Number of Shares

18,174,386

Previous 18,838,691 3.53%

Holding current value

$14.5 Billion

Previous $17.1 Billion 5.6%

% of portfolio

1.32%

Previous 1.5%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$772.14 - $960.02 $513 Million - $638 Million	-664,305 Reduced 3.53%	18,174,386 $16.1 Billion
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $264 Million - $331 Million	-364,272 Reduced 1.9%	18,838,691 $17.1 Billion
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $41.9 Million - $56 Million	-70,722 Reduced 0.37%	19,202,963 $14.9 Billion
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $1.82 Billion - $2.15 Billion	3,470,493 Added 21.96%	19,273,685 $11.2 Billion
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $723 Million - $997 Million	1,663,578 Added 11.77%	15,803,192 $8.49 Billion
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $1.13 Billion - $1.51 Billion	3,228,109 Added 29.58%	14,139,614 $6.63 Billion
Q1 2023 May 18, 2023	BUY	$310.63 - $364.82 $115 Million - $135 Million	371,158 Added 3.52%	10,911,505 $3.75 Billion
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $1.7 Billion - $2 Billion	-5,479,314 Reduced 34.2%	10,540,347 $3.62 Billion
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $406 Million - $473 Million	1,261,226 Added 8.55%	16,019,661 $5.86 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $218 Million - $249 Million	-736,640 Reduced 4.75%	14,758,435 $4.77 Billion
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $223 Million - $262 Million	-801,157 Reduced 4.92%	15,495,075 $5.02 Billion
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $165 Million - $205 Million	-701,646 Reduced 4.13%	16,296,232 $4.67 Billion
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $295 Million - $366 Million	1,312,944 Added 8.37%	16,997,878 $4.7 Billion
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $3.48 Billion - $4.28 Billion	15,684,934 New	15,684,934 $3.62 Billion

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Eli Lilly & CO Transaction History